Clinical trials: T Cell Subsets
Cardiac Transplantation
Outcomes in Pediatric Heart Transplant Recipients Receiving Cellcept
The survival of children who have received heart transplants has greatly improved over the last ten years. One reason for this is better control over rejection.
- Trial name
- NCT00166153
- Testing
- Mycophenolate Mofetil
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- Emory University
Infant, Premature
Vitamin A Supplementation in Preterm Infants
Extremely low birth weight infants have decreased blood levels of Vitamin A. This Vitamin A deficiency may increase the risk of infections and chronic lung disease in these infants.
- Trial name
- NCT00063596
- Testing
- Vitamin A supplementation
- Where
- United States
- Volunteers
- 220 people
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Acute Lymphoblastic Leukemia
Study of huCART19 for Very High-Risk (VHR) Subsets of Pediatric B-ALL
This is a phase 2 study to evaluate humanized CD19 redirected autologous T cells (or huCART19 cells) with CD19 expressing relapsed and refractory B-cell acute lymphoblastic leukemia.
- Trial name
- NCT03792633
- Testing
- huCART19
- Where
- United States
- Volunteers
- 106 people
- Sponsor
- University of Pennsylvania
Celiac Disease
TCRγδ+ Cells After Gluten-free Diet: A Biomarker for Coeliac Disease?
Coeliac disease (CD) is a systemic process of autoimmune nature related to the existence of a permanent intolerance to gluten and manifests itself in genetically susceptible individuals. It has a global prevalence of 0.5-1.5%.
- Trial name
- GFDL (NCT05733663)
- Testing
- Endoscopic procedure with duodenal biopsy
- Where
- Spain
- Volunteers
- 116 people
- Sponsor
- Hospital Mutua de Terrassa